The FTC sued Xlear after it marketed its spray as a covid preventative. The Trump administration dropped the suit, but the ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for bumetanide nasal spray (RSQ-777) for the treatment of edema associated with congestive heart ...

Viraldine 1% Povidone-Iodine Nasal Spray. Price: $18.99 USD; Reviews: 193, with an average rating of 4.8 stars. Purpose: Daily relief formula for sinus pain, congestion, and irritation.

The epinephrine nasal spray, called neffy, is for emergency treatment of allergic reactions, including anaphylaxis, in adult and pediatric patients weighing approximately 66 pounds or more ...

Milestone Pharmaceuticals reports upcoming FDA review for CARDAMYST™ nasal spray targeting PSVT, pending approval by March 2025. Quiver AI Summary.

Soon people will be able to subdue a severe allergic reaction with a nasal spray instead of an injection. On August 9, the U.S. Food and Drug Administration approved the first epinephrine nasal ...

This isn't new territory for the company. In 2022, Green Pharmaceuticals got warnings from the FDA and issued a recall due to microbial contamination in its SnoreStop nasal spray. In June 2022 ...

Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

A nasal spray can tamp down potentially fatal reactions, a boon to the many patients in crisis who fear using EpiPens. Neffy, a new device approved by the Food and Drug Administration, is the ...